ISSN:

Journal Home

Journal Guideline

The Lancet Haematology Q1 Unclaimed

Elsevier Ltd United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

The Lancet Haematology is a journal indexed in SJR in Hematology with an H index of 103. It has an SJR impact factor of 4,936 and it has a best quartile of Q1. It has an SJR impact factor of 4,936.

The Lancet Haematology focuses its scope in these topics and keywords: duration, elastic, therapy, rituximab, prevention, postthrombotic, compression, treatment, syndrome, standard, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Hematology (Q1)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

4,936

SJR Impact factor

103

H Index

192

Total Docs (Last Year)

585

Total Docs (3 years)

3212

Total Refs

3008

Total Cites (3 years)

258

Citable Docs (3 years)

5.39

Cites/Doc (2 years)

16.73

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Blood Q1
Blood Cancer Journal Q1
Leukemia Q1
Experimental Hematology and Oncology Q1
American Journal of Hematology Q1

Compare this journals